Avantor, Inc. Payments of Debt Restructuring Costs
Avantor, Inc. (AVTR) reported Payments of Debt Restructuring Costs of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtRestructuringCosts · last filed 2024-10-25
- Avantor, Inc. payments of debt restructuring costs for the quarter ending 2024-09-30 was $0.00.
- Avantor, Inc. payments of debt restructuring costs for the quarter ending 2023-09-30 was $0.00.
- Avantor, Inc. payments of debt restructuring costs for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Avantor, Inc. payments of debt restructuring costs for the quarter ending 2021-09-30 was $2.40M, a 98.79% decline year-over-year.
| Period end | Payments of Debt Restructuring Costs 3 month | Payments of Debt Restructuring Costs 6 month | Payments of Debt Restructuring Costs 9 month |
|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-25 | $0.00 10-Q · filed 2024-10-25 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-07-26 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-25 | $2.30M 10-Q · filed 2024-10-25 | |
| 2023-06-30 | $2.30M 10-Q · filed 2024-07-26 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $0.00 10-Q · filed 2023-10-27 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-07-28 | ||
| 2021-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $22.50M 10-Q · filed 2022-10-28 | |
| 2021-06-30 | $20.10M 10-Q · filed 2022-07-29 | ||
| 2020-09-30 | $198.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $198.00M 10-Q · filed 2021-10-29 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-07-30 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |